Prothena Corp. Plc (PRTA)
9.38
-0.07
(-0.74%)
USD |
NASDAQ |
Aug 24, 16:00
9.38
0.00 (0.00%)
After-Hours: 20:00
Prothena Enterprise Value : 207.78M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 207.78M |
| August 20, 2026 | 186.05M |
| August 19, 2026 | 199.50M |
| August 18, 2026 | 169.49M |
| August 17, 2026 | 178.29M |
| August 14, 2026 | 177.25M |
| August 13, 2026 | 188.64M |
| August 12, 2026 | 197.95M |
| August 11, 2026 | 195.88M |
| August 10, 2026 | 190.71M |
| August 07, 2026 | 172.08M |
| August 06, 2026 | 162.76M |
| August 05, 2026 | 158.11M |
| August 04, 2026 | 158.11M |
| August 03, 2026 | 149.83M |
| July 31, 2026 | 138.96M |
| July 30, 2026 | 153.97M |
| July 29, 2026 | 161.73M |
| July 28, 2026 | 161.73M |
| July 27, 2026 | 168.97M |
| July 24, 2026 | 171.56M |
| July 23, 2026 | 160.18M |
| July 22, 2026 | 155.52M |
| July 21, 2026 | 171.56M |
| July 20, 2026 | 167.42M |
| Date | Value |
|---|---|
| July 17, 2026 | 166.90M |
| July 16, 2026 | 157.07M |
| July 15, 2026 | 155.00M |
| July 14, 2026 | 165.87M |
| July 13, 2026 | 175.70M |
| July 10, 2026 | 196.92M |
| July 09, 2026 | 217.61M |
| July 08, 2026 | 228.48M |
| July 07, 2026 | 219.68M |
| July 06, 2026 | 210.37M |
| July 02, 2026 | 220.20M |
| July 01, 2026 | 214.51M |
| June 30, 2026 | 225.37M |
| June 29, 2026 | 207.37M |
| June 26, 2026 | 210.03M |
| June 25, 2026 | 170.22M |
| June 24, 2026 | 177.12M |
| June 23, 2026 | 185.08M |
| June 22, 2026 | 163.85M |
| June 18, 2026 | 152.17M |
| June 17, 2026 | 128.82M |
| June 16, 2026 | 118.20M |
| June 15, 2026 | 110.77M |
| June 12, 2026 | 116.08M |
| June 11, 2026 | 116.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alkermes Plc | 9.013B |
| Amarin Corp. Plc | -13.67M |
| Agenus, Inc. | 609.42M |
| Amgen, Inc. | 280.82B |
| Anika Therapeutics, Inc. | 278.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.58M |
| Revenue (Quarterly) | 1.01M |
| Total Expenses (Quarterly) | 19.59M |
| EPS Diluted (Quarterly) | -0.3564 |
| Gross Profit Margin (Quarterly) | 9.50% |
| Profit Margin (Quarterly) | -1.84K% |
| Earnings Yield | -8.86% |
| Normalized Earnings Yield | -9.455 |